Monday, February 21, 2022

New Advanced Monitoring for People Living with Heart Failure

(updated): Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for the company’s CardioMEMS™ HF System to support the care of more people living with heart failure. With the expanded indication, an additional 1.2 million U.S. patients1 are now eligible to benefit from advanced monitoring with the CardioMEMS sensor, which marks a significant increase over the current addressable population. The sensor provides an early warning system enabling doctors to protect against worsening heart failure. […] - eTurboNews | eTN

No comments:

Post a Comment